Comparison of Three Lateral Flow Immunoassay Formats for the Detection of Antibodies against the SARS-CoV-2 Antigen

Reliable detection of specific antibodies against pathogens by lateral flow immunoassay (LFIA) greatly depends on the composition of the detectable complex and the order of its assembly. We compared three LFIA formats for revealing anti-SARS-CoV-2 antibodies in sera with the following detected compl...

Full description

Bibliographic Details
Main Authors: Dmitriy V. Sotnikov, Nadezhda A. Byzova, Anatoly V. Zherdev, Youchun Xu, Boris B. Dzantiev
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Biosensors
Subjects:
Online Access:https://www.mdpi.com/2079-6374/13/7/750
_version_ 1797590011836628992
author Dmitriy V. Sotnikov
Nadezhda A. Byzova
Anatoly V. Zherdev
Youchun Xu
Boris B. Dzantiev
author_facet Dmitriy V. Sotnikov
Nadezhda A. Byzova
Anatoly V. Zherdev
Youchun Xu
Boris B. Dzantiev
author_sort Dmitriy V. Sotnikov
collection DOAJ
description Reliable detection of specific antibodies against pathogens by lateral flow immunoassay (LFIA) greatly depends on the composition of the detectable complex and the order of its assembly. We compared three LFIA formats for revealing anti-SARS-CoV-2 antibodies in sera with the following detected complexes in the analytical zone of the strip: antigen–antibodies–labeled immunoglobulin-binding protein (Scheme A); antigen–antibodies–labeled antigen (Scheme B); and immunoglobulin-binding protein–antibodies–labeled antigen (Scheme C). The lowest detection limit was observed for Scheme C, and was equal to 10 ng/mL of specific humanized monoclonal antibodies. When working with pooled positive sera, Scheme C had a detection limit 15 times lower than Scheme B and 255 times lower than Scheme A. Due to the high sensitivity of Scheme C, its application for the panel of human sera (n = 22) demonstrated 100% diagnostic specificity and sensitivity. These consistent results be useful for designing the format of LFIA serodiagnosis for other diseases.
first_indexed 2024-03-11T01:14:18Z
format Article
id doaj.art-1c9b98e684194a02b5a8d9ce40c9b67d
institution Directory Open Access Journal
issn 2079-6374
language English
last_indexed 2024-03-11T01:14:18Z
publishDate 2023-07-01
publisher MDPI AG
record_format Article
series Biosensors
spelling doaj.art-1c9b98e684194a02b5a8d9ce40c9b67d2023-11-18T18:33:29ZengMDPI AGBiosensors2079-63742023-07-0113775010.3390/bios13070750Comparison of Three Lateral Flow Immunoassay Formats for the Detection of Antibodies against the SARS-CoV-2 AntigenDmitriy V. Sotnikov0Nadezhda A. Byzova1Anatoly V. Zherdev2Youchun Xu3Boris B. Dzantiev4A.N. Bach Institute of Biochemistry, Research Center of Biotechnology of the Russian Academy of Sciences, Leninsky Prospect 33, 119071 Moscow, RussiaA.N. Bach Institute of Biochemistry, Research Center of Biotechnology of the Russian Academy of Sciences, Leninsky Prospect 33, 119071 Moscow, RussiaA.N. Bach Institute of Biochemistry, Research Center of Biotechnology of the Russian Academy of Sciences, Leninsky Prospect 33, 119071 Moscow, RussiaState Key Laboratory of Membrane Biology, Department of Biomedical Engineering, School of Medicine, Tsinghua University, Beijing 100084, ChinaA.N. Bach Institute of Biochemistry, Research Center of Biotechnology of the Russian Academy of Sciences, Leninsky Prospect 33, 119071 Moscow, RussiaReliable detection of specific antibodies against pathogens by lateral flow immunoassay (LFIA) greatly depends on the composition of the detectable complex and the order of its assembly. We compared three LFIA formats for revealing anti-SARS-CoV-2 antibodies in sera with the following detected complexes in the analytical zone of the strip: antigen–antibodies–labeled immunoglobulin-binding protein (Scheme A); antigen–antibodies–labeled antigen (Scheme B); and immunoglobulin-binding protein–antibodies–labeled antigen (Scheme C). The lowest detection limit was observed for Scheme C, and was equal to 10 ng/mL of specific humanized monoclonal antibodies. When working with pooled positive sera, Scheme C had a detection limit 15 times lower than Scheme B and 255 times lower than Scheme A. Due to the high sensitivity of Scheme C, its application for the panel of human sera (n = 22) demonstrated 100% diagnostic specificity and sensitivity. These consistent results be useful for designing the format of LFIA serodiagnosis for other diseases.https://www.mdpi.com/2079-6374/13/7/750immunochromatographyCOVID-19serodiagnosticsimmune complexesserum testing
spellingShingle Dmitriy V. Sotnikov
Nadezhda A. Byzova
Anatoly V. Zherdev
Youchun Xu
Boris B. Dzantiev
Comparison of Three Lateral Flow Immunoassay Formats for the Detection of Antibodies against the SARS-CoV-2 Antigen
Biosensors
immunochromatography
COVID-19
serodiagnostics
immune complexes
serum testing
title Comparison of Three Lateral Flow Immunoassay Formats for the Detection of Antibodies against the SARS-CoV-2 Antigen
title_full Comparison of Three Lateral Flow Immunoassay Formats for the Detection of Antibodies against the SARS-CoV-2 Antigen
title_fullStr Comparison of Three Lateral Flow Immunoassay Formats for the Detection of Antibodies against the SARS-CoV-2 Antigen
title_full_unstemmed Comparison of Three Lateral Flow Immunoassay Formats for the Detection of Antibodies against the SARS-CoV-2 Antigen
title_short Comparison of Three Lateral Flow Immunoassay Formats for the Detection of Antibodies against the SARS-CoV-2 Antigen
title_sort comparison of three lateral flow immunoassay formats for the detection of antibodies against the sars cov 2 antigen
topic immunochromatography
COVID-19
serodiagnostics
immune complexes
serum testing
url https://www.mdpi.com/2079-6374/13/7/750
work_keys_str_mv AT dmitriyvsotnikov comparisonofthreelateralflowimmunoassayformatsforthedetectionofantibodiesagainstthesarscov2antigen
AT nadezhdaabyzova comparisonofthreelateralflowimmunoassayformatsforthedetectionofantibodiesagainstthesarscov2antigen
AT anatolyvzherdev comparisonofthreelateralflowimmunoassayformatsforthedetectionofantibodiesagainstthesarscov2antigen
AT youchunxu comparisonofthreelateralflowimmunoassayformatsforthedetectionofantibodiesagainstthesarscov2antigen
AT borisbdzantiev comparisonofthreelateralflowimmunoassayformatsforthedetectionofantibodiesagainstthesarscov2antigen